Insights
BSKB’s intellectual property attorneys write articles on important and timely topics in intellectual property law across a variety of industries. You’ll find the latest articles and industry insights here.
-
September 8, 2023
USPTO proposals could increase burden on TM counsel
Managing IP
BSKB Partner Michael Smith was recently quoted in an article for Managing IP.
-
May 25, 2023
AI and blockchain: a guide to overcoming 101 rejections
World Intellectual Property Review Iss. 1
Mr. Bradford Fritz and Mr. Alexander Taousakis were recently published in World IP Review’s latest edition of World IP Review.
-
February 16, 2023
Amgen v. Sanofi – When Functional Language in Patents Malfunctions
Law360
How High Court Amgen Case Could Alter Patent Enablement
-
December 29, 2022
Key Topics in IP for 2023
IPWatchdog
Eugene Perez is quoted in IPWatchdog discussing key issues to watch in 2023
-
December 26, 2022
Key U.S. Supreme Court Developments in 2022 and Outlook for 2023
IPWatchdog
As the 2022 year comes to an end, Dr. Hailey Bureau reflects on the Intellectual Property industry and the key SCOTUS decisions of 2022 that impacted patent and trademark law.
-
November 16, 2022
From the TTAB - The RV Factory, LLC granted Petition for Cancellation
Trademark Trial and Appeal Board
BSKB would like to congratulate The RV Factory for successfully petitioning to cancel US Registration No. 5252621. The Trademark Trial and Appeal Board has granted the Petition of Cancellation on November 16, 2022, Cancellation No. 92068961.
-
October 11, 2022
"A new prescription for negative claim limitations"
World IP Review
Dr. Hailey Bureau was recently published in World IP Review’s latest digital edition of World IP Review.
-
July 1, 2022
"Pharma Patents Under Fire From Federal Circuit, Petitions Say"
Bloomberg Law
BSKB's Hailey R. Bureau, Ph.D., was quoted in an article for Bloomberg Law regarding recent rulings by the US Court of Appeals for the Federal Circuit regarding strict enforcement of certain Patent Act provisions. These rulings regarding Section 112(a), a written description requirement and an enablement standard, have created a high burden for Applicants in the life science industry to overcome.
-
June 21, 2022
Who Owns ‘Skin’? Kardashian’s ‘SKKN’ Facing Trademark Ambiguity
Bloomberg Law
BSKB Partner Michael T. Smith was quoted recently in an article regarding Kim Kardashian's new skin care line, "SKKN by Kim".
-
May 20, 2022
Benchmarking Adaptive Steered Molecular Dynamics (ASMD) on CHARMM Force Fields
Chemistry Europe: European Chemical Societies Publishing
BSKB’s Hailey Bureau, Ph.D., co-authored a research article entitled “Benchmarking Adaptive Steered Molecular Dynamics (ASMD) on CHARMM Force Fields”. Although prepared during her time in graduate school, the paper has now been published on May 20, 2022 in ChemPhysChem.
-
April 29, 2022
Responding to Examiner Rejections in Chem/Pharma/Bio Applications
Patent Law Institute
BSKB’s Chad Rink recently co-lectured with Briana Barron during the 2022 Patent Law Institute (PLI) virtual meeting. Their topic was “Responding to Examiner Rejections in Chem/Pharma/Bio Applications.” Chad and Briana discussed recent court decisions covering written description, obviousness, and inequitable conduct.
-
April 26, 2022
Label Ruling Upends Generic Medicine Makers
WIPR
The effects of the ‘skinny label’ decision are being felt across pharma. MaryAnne Armstrong of Birch, Stewart, Kolasch & Birch revisits GSK v Teva.
-
April 13, 2022
Podcast: Leonard Svensson (BSKB) remarks on Impossible Food’s recent legal issues
Bloomberg Law Podcast
In this week's Bloomberg Law Podcast, BSKB’s Leonard Svensson is featured discussing how “Impossible Foods is testing a tastes-like-meat patent in court.”
-
January 5, 2022
Patent applications: Kite raises the game
Patent applications: Kite raises the game
Hailey Bureau, Ph.D. (Associate) and Olayinka Oladele (Law Clerk from Texas Southern University's Thurgood Marshall School of Law) recently co-authored and article for WIPR regarding the Federal Circuit's recent "added complexities to the drafting of patent applications for antibody inventions" as a result of the cases Amgen v Sanofi (2021) and Juno Therapeutics v Kite Pharma (2021).
-
September 30, 2021
Eugene Perez weighs in on the “Restoring America Invents Act”
IPWatchdog
Eugene Perez weighs in on the “Restoring America Invents Act”, proposed by Senators Leahy (D-VT) and Cornyn (R-TX), in an article from IPWatchdog, Inc
-
September 27, 2021
Q&A with David Bilodeau and Brad Fritz: Rain Computing v. Samsung
WIPR Patents Live
WIPR Patents Live hosted BSKB Attorneys David Bilodeau (Partner) and Brad Fritz (Associate) in a Q&A with Tom Phillips regarding Rain Computing v. Samsung.
-
September 16, 2021
MaryAnne Armstrong, PhD, offers her perspective on the "impact of the America Invents Act"
IPWatchdog
MaryAnne Armstrong, PhD, offers her perspective on the "impact of the America Invents Act" during the bill's 10 year anniversary in an article from IPWatchdog, Inc.
-
July 7, 2021
When the Inventor is Artificial
LSIPR
MaryAnne Armstrong discusses whether the same tests for non-obviousness of biotech patents will be applied to pharma inventions developed using AI.
-
June 22, 2021
Industry Reacts to the Supreme Court’s Arthrex Ruling: Chaos Averted – or Just Delayed?
IPWatchdog
Partner, Eugene T. Perez was recently quoted in an article by IPWatchdog regarding this week's U.S. Supreme Court patent decision in United States v. Arthrex, Inc. Et Al.
-
June 17, 2021
Q&A with MaryAnne Armstrong: The future of AI in the life sciences
LSIPR
MaryAnne Armstrong, Ph. D., sits down with LSIPR to discuss artificial intelligence's impact on IP industry relating to life sciences and pharmaceuticals.